Anti-inflammatory Drugs Market Will Grow At Highest Pace Owing To Rising Prevalence Of Arthritis

The anti-inflammatory drugs market comprises drugs that are primarily used to relieve pain, fever and inflammation. These drugs work by blocking the production of chemicals in the body that cause inflammation, fever and pain. Some of the common anti-inflammatory drugs available in the market include aspirin, ibuprofen, naproxen, diclofenac and corticosteroids. Aspirin is one of the most commonly used anti-inflammatory drugs owing to its cost-effectiveness. It acts by inhibiting the activity of COX-1 and COX-2 enzymes which are responsible for inflammation and pain. Ibuprofen and naproxen also work by blocking these enzymes. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that is effective in treating arthritis and other musculoskeletal conditions. Corticosteroids like prednisone are potent anti-inflammatory drugs that are prescribed for conditions like rheumatoid arthritis. The global anti-inflammatory drugs market is estimated to be valued at US$ 118.21 Bn in 2024 and is expected to exhibit a CAGR of 5.5% over the forecast period 2024 to 2031.

Key Takeaways
Key players operating in the Anti-Inflammatory Drugs Market Growth are 48 London, Alpine Escape, Arburton Ltd, Aspen Luxury Concierge Service LLC, AZ Luxe, Bon Vivant, Globe Infinite, Ibiza Luxury Concierge Service, Innerplace Co., and John Paul. The rising prevalence of arthritis is a major factor driving the demand for anti-inflammatory drugs globally. According to the Arthritis Foundation, around 1.3 million Americans are diagnosed with arthritis each year. NSAIDs are commonly used to treat arthritis and other joint pains and muscle aches. Technological advancements have led to the development of long-acting anti-inflammatory molecules that require less frequent dosing. For instance, drugs such as celecoxib provide pain relief for 24 hours with single daily dosing.

Market Trends
Growing geriatric population: The risk of arthritis and other joint disorders increases with age. As life expectancy rises across the globe, the senior population aged 65 years or older is growing rapidly which will augment the anti-inflammatory drugs market.

Development of biologic therapies: Biologics that target specific molecules involved in the inflammation process are shifting treatment patterns. Biologics like Humira and Enbrel are very effective in treating severe arthritis and have gained popularity.

Market Opportunities
Emerging markets: There is significant scope for market growth in developing regions owing to large patient pools and increasing healthcare expenditures.

Self-administrable drugs: Convenient formulations like topical creams and gels are gaining traction as they can be easily applied and provide localized pain relief without systemic side effects.

Impact of COVID-19 on ANTI-INFLAMMATORY DRUGS Market Growth
The COVID-19 pandemic has significantly impacted the global ANTI-INFLAMMATORY DRUGS market. While the demand for the drugs has surged post the outbreak due to their usage in treating COVID-19 symptoms, the supply chain disruptions have hindered the market growth. The nationwide lockdowns enforced to curb the virus spread restricted the movement of goods and people. This created bottlenecks in production and transportation activities across countries. The disrupted supply chains led to shortage of raw materials and skilled workforce, thereby impacting the manufacturing output of pharma companies. However, with countries gradually lifting mobility restrictions, the industry players are now working towards normalizing operations. They are adopting safety protocols and innovative supply chain management strategies to meet the growing demand amid the crisis. Going forward, the market is expected to witness steady growth as companies enhance production capacities to cater to COVID-19 treatment needs while ensuring seamless supply flows.

Geographical Regions with High Market Concentration
In terms of value, the North American region holds the major share of over 35% in the global ANTI-INFLAMMATORY DRUGS market. This is attributed to the well-established healthcare infrastructure and higher spending on prescription drugs in countries like the US and Canada. The Asia Pacific region has also emerged as a lucrative market in recent years with around 25% share, led by the rising elderly population, increasing healthcare expenditures and burgeoning pharmaceutical industry in nations such as China, Japan and India. Additionally, the growing medical tourism sector has supported the market growth in regions including Latin America and the Middle East and Africa.

Fastest Growing Region - Asia Pacific
The Asia Pacific region is poised to be the fastest growing market for ANTI-INFLAMMATORY DRUGS at a CAGR of around 7% during the forecast period. This can be accredited to the expanding consumer base, rapid economic development, rising healthcare awareness and improving access to medicines across developing nations. Rapid urbanization along with the increasing prevalence of chronic inflammatory diseases has augmented the drug consumption in the region. Moreover, favorable regulations, low manufacturing costs and skilled labor availability have attracted several industry players to set up production facilities in Asia Pacific countries. This will further drive the regional market growth over the next few years.

Get more insights on Anti-Inflammatory Drugs Market

Also read related article on Bioreactors Market